Co Morbid Attention Deficit and Hyperactivity Disorder(ADHD) and Developmental Co Ordination Disorder (DCD)

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

May 2, 2018

Primary Completion Date

May 30, 2019

Study Completion Date

May 30, 2019

Conditions
Attention Deficit Disorder With HyperactivityDevelopmental Coordination Disorder
Interventions
DRUG

Neurostimulant pharmaceutical drugs

The Pi will only administer the exercise intervention. This will consist of minimum of 8 sessions of group exercises, working on improving muscle tone, core stability, balance, fine and gross motor skills and visual motor integration. The pharmacological therapy will be administered and monitored by medical practitioners, as is the norm with most children diagnosed and treated for ADHD/ADD. Parents of participants will remain responsible entirely for the monitoring of the pharmacological therapy of their children.

Trial Locations (1)

4600

Escombe Primary School, Durban

All Listed Sponsors
lead

University of KwaZulu

OTHER

NCT03595826 - Co Morbid Attention Deficit and Hyperactivity Disorder(ADHD) and Developmental Co Ordination Disorder (DCD) | Biotech Hunter | Biotech Hunter